Jinming Qi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jinming Qi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Lijuan Shen
State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China
4 shared publications- Tao Hu
State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China
4 shared publications Weili Yu
State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China
4 shared publicationsLucheng Xiao
State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100190, China
2 shared publicationsYunxia He
State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100190, China
2 shared publicationsWenying Yan
State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100190, China
1 shared publication
Latest Publications
- 21 September 2022
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 222 (Pt A) , 661-670
A SARS-CoV-2 vaccine based on conjugation of SARS-CoV-2 RBD with IC28 peptide and mannan
- 21 September 2022
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 222 (Pt A) , 661-670
A SARS-CoV-2 vaccine based on conjugation of SARS-CoV-2 RBD with IC28 peptide and mannan
- 6 June 2022
- Published by Elsevier in International Immunopharmacology
- Vol. 109, 108922
Conjugation with 8-arm PEG and CRM197 enhances the immunogenicity of SARS-CoV-2 ORF8 protein
- 6 June 2022
- Published by Elsevier in International Immunopharmacology
- Vol. 109, 108922
Conjugation with 8-arm PEG and CRM197 enhances the immunogenicity of SARS-CoV-2 ORF8 protein
- 18 February 2022
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 172, 193-202
Conjugation with loxoribine and mannan improves the immunogenicity of Mycobacterium tuberculosis CFP10-TB10.4 fusion protein
- 18 February 2022
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 172, 193-202
Conjugation with loxoribine and mannan improves the immunogenicity of Mycobacterium tuberculosis CFP10-TB10.4 fusion protein
- 1 November 2021
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 190, 713-721
Conjugation of Zika virus EDIII with CRM197, 8-arm PEG and mannan for development of an effective Zika virus vaccine
- 1 November 2021
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 190, 713-721
Conjugation of Zika virus EDIII with CRM197, 8-arm PEG and mannan for development of an effective Zika virus vaccine